Infectious Disease Alert – November 1, 2005
November 1, 2005
View Archives Issues
-
Antibacterial Prophylaxis for Patients with Cancer: Should We Use It or Not?
The Ginema study reported by Bucaneve and colleagues recruited for a formal, double-blind, randomized placebo controlled trial of 500 mg/d levofloxacin among 760 patients who were admitted to the hospital and who were at risk of developing neutropenia resulting from treatment of acute leukemia lymphoma or solid tumors. -
The Effect of Antibiotic Therapy for Intraabdominal Infections on Selection of Antibiotic-Resistant Bowel Flora
Several randomized, comparative trials have demonstrated the efficacy of ertapenem in the treatment of patients with intraabdominal infections. -
Valproic Acid for HIV Infection
This proof of concept clinical trial intensively studied 4 patients with HIV infection who had plasma levels of HIV RNA below the lower limit of quantification in a standard viral load assay on standard HAART therapy. -
Giardiasis and the Risks of Visiting Grandma
Giardiasis, caused by the waterborne protozoan parasite Giardia lamblia, also known as G. intestinalis, and G. duodenalis, is a common cause of diarrhea worldwide. -
Updates by Carol A Kemper
Following an educational campaign promoting hand washing in public places, and observing 6300 people using public restrooms at various locations across the United States, researchers report slow but steady improvement in rates of hand washing. But men are still not as rigorous as women about their personnel hygiene. -
Pharmacology Watch: Roche is Under Pressure Over Its Antiviral Drug Tamiflu
ACE Inhibitors or ARBs for Prediabetics?; Xigris is Approved for Severe Sepsis; ACE Inhibitors Inhibiting Aortic Valve Stenosis?; FDA Actions -
Clinical Briefs in Primary Care supplement